Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16-week, randomized, placebo-controlled trial (Q87027517)
Jump to navigation
Jump to search
scientific article published on 13 May 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16-week, randomized, placebo-controlled trial |
scientific article published on 13 May 2015 |
Statements
Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16-week, randomized, placebo-controlled trial (English)
S Ross
C Thamer
J Cescutti
T Meinicke
H J Woerle